Compare · ISRG vs MYO
ISRG vs MYO
Side-by-side comparison of Intuitive Surgical Inc. (ISRG) and Myomo Inc. (MYO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ISRG and MYO operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ISRG is the larger of the two at $162.13B, about 4678.7x MYO ($34.7M).
- Over the past year, ISRG is down 13.5% and MYO is down 81.7% - ISRG leads by 68.1 points.
- ISRG has been more active in the news (15 items in the past 4 weeks vs 11 for MYO).
- ISRG has more recent analyst coverage (25 ratings vs 3 for MYO).
- Company
- Intuitive Surgical Inc.
- Myomo Inc.
- Price
- $457.85-0.03%
- $0.89+2.96%
- Market cap
- $162.13B
- $34.7M
- 1M return
- -1.43%
- +32.92%
- 1Y return
- -13.54%
- -81.66%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- AMEX
- IPO
- 2000
- 2017
- News (4w)
- 15
- 11
- Recent ratings
- 25
- 3
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Myomo Inc.
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to restore function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Latest ISRG
- SEC Form 4 filed by Director Guthart Gary S
- Director Reed Monica P converted options into 531 shares, increasing direct ownership by 23% to 2,876 units (SEC Form 4)
- Director Nachtsheim Jami K converted options into 531 shares, increasing direct ownership by 8% to 6,902 units (SEC Form 4)
- Director Leonard Keith R converted options into 531 shares, increasing direct ownership by 144% to 901 units (SEC Form 4)
- Director Ladd Amy L converted options into 531 shares, increasing direct ownership by 442% to 651 units (SEC Form 4)
- Director Kolli Sreelakshmi converted options into 531 shares, increasing direct ownership by 54% to 1,510 units (SEC Form 4)
- Director Johnson Amal M converted options into 531 shares, increasing direct ownership by 4% to 13,545 units (SEC Form 4)
- Director Chew Lewis converted options into 531 shares, increasing direct ownership by 68% to 1,314 units (SEC Form 4)
- Director Beery Joseph C converted options into 531 shares, increasing direct ownership by 17% to 3,641 units (SEC Form 4)
- Director Barratt Craig H converted options into 750 shares (SEC Form 4)
Latest MYO
- Myomo to Report First Quarter 2026 Financial Results on May 7
- Amendment: SEC Form 10-K/A filed by Myomo Inc.
- Myomo Introduces Myomo Mobile App to Enhance Clinical Workflow and Patient Engagement
- SEC Form 4 filed by Febbo William J
- SEC Form 3 filed by new insider Febbo William J
- Myomo Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Myomo Appoints William J Febbo to its Board of Directors
- Amendment: SEC Form 4 filed by Gudonis Paul R
- SEC Form 4 filed by Henry David A
- SEC Form 4 filed by Gudonis Paul R